Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats

In the present study the effects of kynurenine and its metabolite kynurenic acid were compared in different behavioral and pharmacological tests. Kynurenic acid administered i.c.v. resulted in ataxia and sterotype in a dose-dependent manner (0.025-1.6-mu-mol). Administration of 0.8-mu-mol of kynuren...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Vécsei László
Beal Flint M.
Dokumentumtípus: Cikk
Megjelent: 1991
Sorozat:EUROPEAN JOURNAL OF PHARMACOLOGY 196 No. 3
doi:10.1016/0014-2999(91)90436-T

mtmt:1032284
Online Access:http://publicatio.bibl.u-szeged.hu/10553
LEADER 02822nab a2200217 i 4500
001 publ10553
005 20190725140257.0
008 170215s1991 hu o 0|| zxx d
022 |a 0014-2999 
024 7 |a 10.1016/0014-2999(91)90436-T  |2 doi 
024 7 |a 1032284  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Vécsei László 
245 1 0 |a Comparative behavioral and pharmacological studies with centrally administered kynurenine and kynurenic acid in rats  |h [elektronikus dokumentum] /  |c  Vécsei László 
260 |c 1991 
300 |a 239-246 
490 0 |a EUROPEAN JOURNAL OF PHARMACOLOGY  |v 196 No. 3 
520 3 |a In the present study the effects of kynurenine and its metabolite kynurenic acid were compared in different behavioral and pharmacological tests. Kynurenic acid administered i.c.v. resulted in ataxia and sterotype in a dose-dependent manner (0.025-1.6-mu-mol). Administration of 0.8-mu-mol of kynurenic acid resulted in sleeping and an approximate 25% mortality of the animals. At a dose of 1.6-mu-mol all of the animals died within 2-5 min from cardiorespiratory failure. One hour after lower doses of kynurenic acid the behavior of the rats appeared normal (neither stereotypy nor ataxia were observed in their familiar environment), but their exploratory activity (0.025-0.2-mu-mol) was significantly lower in a novel environment (open-field box) compared to the control group. Twenty four hours after the injection of kynurenic acid the exploratory activity of the animals did not differ from the control group. Kynurenine administered i.c.v. in equimolar doses did not result in stereotypy, ataxia, sleeping or mortality of the animals although, immediately after high doses short-lasting (1-2 min) immobility was observed. The rearing activity of the high dose kynurenine-treated animals was lower 1 h after injection, but this effect disappeared 24 h after the treatment. Post-trial injection of kynurenic acid (0.2-mu-mol) slightly, but not significantly, inhibited the learning ability of the rats in an active avoidance paradigm. Kynurenine administered in an equimolar dose had no effect on the speed of learning, but significantly attenuated the intertrial activity of the rats. Kynurenic acid (0.2-mu-mol, 0.4-mu-mol) did not significantly inhibit the passive avoidance latency of the animals after post-trial treatment. These findings suggest that i.c.v. administration of kynurenic acid results in marked acute behavioral changes while equimolar doses of kynurenine had only slight behavior effects. The present experiments and earlier behavioral data suggest that the NMDA receptor complex plays a role in specific cognitive functions. 
700 0 1 |a Beal Flint M.  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/10553/7/1032284.pdf  |z Dokumentum-elérés